Clinical Trial Update: Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis

View source ↗

Summary

A clinical trial evaluating intravenous paricalcitol (Zemplar IV) in patients with end-stage chronic kidney disease on haemodialysis for management of secondary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Zemplar IV (paricalcitol)

Snippet

Sponsor: Abbott | Conditions: Parathyroid Hormone | Status: COMPLETED | Results posted: 2011-09-12